Precigen, Inc. approved performance stock units (PSUs) for key employees, including executives, tied to achieving specific operational milestones related to FDA submissions and approvals, with a total of 2,258,000 PSUs granted. The PSUs will vest based on the company's performance and continued employment, with specific conditions for termination and change in control.